Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Prostate (BPH), Bladder & Urinary Tract

Prostate (BPH), Bladder & Urinary Tract (128 Condition Guides)

Benign prostatic hyperplasia (BPH), urinary tract infections, overactive bladder, and kidney stones.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Prostate (BPH), Bladder & Urinary Tract Guides (128)

Clear Filter × Page 1 of 4

Abscess of prostate

Abscess of prostate (ICD-10-CM N41.2) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Acute cystitis with hematuria

Acute cystitis with hematuria (ICD-10-CM N30.01) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Acute cystitis without hematuria

Acute cystitis without hematuria (ICD-10-CM N30.00) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Acute prostatitis

Designated in federal medical registries as N41.0, Acute prostatitis falls under Urology & Prostate management, where urinalysis/urine culture [Acute prostatitis N41.0] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Adenosis - sclerosing

Adenosis - sclerosing—coded clinically as N64.59 across Urology & Prostate guidelines—combines urinalysis/urine culture [Adenosis - sclerosing N64.59] with structured follow-up of IPSS Urinary Symptom in Adenosis - sclerosing (N64.59: Score) (0 – 7 (mild symptoms) (N64.59)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Air Pollution

Air pollution is a mixture of solid particles and gases in the air. Car emissions, chemicals from factories, dust, pollen and mold spores may be suspended as particles. Ozone, a gas, is a major part of air pollution in cities. When ozone forms air pollution, it's also called smog. Some air pollutants are poisonous. Inhaling them can increase the chance you'll have health problems. People with heart or lung disease, older adults and children are at greater risk from air pollution. Air pollution isn't just outside - the air inside buildings can also be polluted and affect your health. Environmental Protection Agency

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Balanitis

Balanitis (ICD-10-CM N48.1) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bartholin's gland cyst

Designated in federal medical registries as N75.0, Bartholin's gland cyst falls under Urology & Prostate management, where urinalysis/urine culture [Bartholin's gland cyst N75.0] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bedwetting (Enuresis)

Also called: Enuresis

Bedwetting (Enuresis) (ICD-10-CM N39.44) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Benign prostatic hypertrophy (BPH)

Also called: Benign prostatic hypertrophy • Prostate • Prostatic

Benign prostatic hypertrophy (BPH) (ICD-10-CM N40.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bladder - neurogenic

Bladder - neurogenic (ICD-10-CM N31.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bladder Diseases

Also called: Macro • Large

The bladder is a hollow organ in your lower abdomen that stores urine. Many conditions can affect your bladder. Some common ones are: Cystitis - inflammation of the bladder, often from an infection Urinary incontinence - loss of bladder control Overactive bladder - a condition in which the bladder squeezes urine out at the wrong time Interstitial cystitis - a chronic problem that causes bladder pain and frequent, urgent urination Bladder cancer Doctors diagnose bladder diseases using different tests. These include urine tests, x-rays, and an examination of the bladder wall with a scope called a cystoscope. Treatment depends on the cause of the problem.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bladder outlet obstruction

Also called: Stroke

Bladder outlet obstruction (ICD-10-CM N32.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bladder spasm

Bladder spasm (ICD-10-CM N32.89) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bladder stone

Bladder stone (ICD-10-CM N21.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Bowel Incontinence

Also called: Encopresis • Fecal incontinence • Stool soiling

Bowel incontinence is the inability to control your bowels. When you feel the urge to have a bowel movement, you may not be able to hold it until you get to a toilet. Millions of Americans have this problem. It affects people of all ages - children and adults. It is more common in women and older adults. It is not a normal part of aging. Causes include: Constipation Damage to muscles or nerves of the anus and rectum Diarrhea Pelvic floor disorders Treatments include changes in diet, medicines, bowel training, or surgery.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Breast abscess

Breast abscess (ICD-10-CM N61.1) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast calcification

Breast calcification (ICD-10-CM N64.89) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast discharge

Breast discharge (ICD-10-CM N64.52) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast disease - fibrocystic

Breast disease - fibrocystic (ICD-10-CM N60.19) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast mass

Breast mass (ICD-10-CM N63.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast pain

Also called: Hurt • Cramp

Breast pain (ICD-10-CM N64.4) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Breast tender

Breast tender (ICD-10-CM N64.4) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Calculus of kidney

Calculus of kidney (ICD-10-CM N20.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Calculus of kidney with calculus of ureter

Calculus of kidney with calculus of ureter (ICD-10-CM N20.2) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Calculus of ureter

Designated in federal medical registries as N20.1, Calculus of ureter falls under Urology & Prostate management, where alpha-1 blockers [Calculus of ureter N20.1] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic membranoproliferative glomerulonephritis

Chronic membranoproliferative glomerulonephritis (ICD-10-CM N05.5) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic prostatitis

Chronic prostatitis (ICD-10-CM N41.1) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Circumcision

Circumcision is a surgical procedure to remove the foreskin from the penis. The foreskin is the loose skin that covers the tip of the penis. In the United States, circumcision is often done before a new baby leaves the hospital. What should I consider when deciding whether to have my baby circumcised? As parents, it is your decision whether to have your baby circumcised. When making your decision, you should consider your own religious, cultural, and personal preferences, as well as the medical benefits and risks. You can discuss these with your baby's health care provider before you make a decision.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Clinical Trials

Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose, or treat a disease. Clinical trials may also compare a new treatment to a treatment that is already available. Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. Each study has its own rules about who can take part. Some studies need volunteers with a certain disease. Some need healthy people. Others want just men or just women.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Continuous leakage

Designated in federal medical registries as N39.45, Continuous leakage falls under Urology & Prostate management, where urinalysis/urine culture [Continuous leakage N39.45] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Cystitis

Cystitis—coded clinically as N30.90 across Urology & Prostate guidelines—combines 5-alpha-reductase volume reduction [Cystitis N30.90] with structured follow-up of Urinalysis & Post-Void in Cystitis (N30.90: Residual (PVR)) (Negative leukocyte/nitrite; PVR < 50 mL (N30.90)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Cystitis glandularis

Cystitis glandularis (ICD-10-CM N30.80) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Disorder of urinary system

Disorder of urinary system (ICD-10-CM N39.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Prostate (BPH), Bladder & Urinary Tract on dotMD.com?

dotMD.com maps Prostate (BPH), Bladder & Urinary Tract against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Prostate (BPH), Bladder & Urinary Tract visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee